Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality
JAMA Cardiology
JANUARY 21, 2025
This cohort study investigates the association of supine hypertension with cardiovascular disease and mortality in middle-aged adults.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
JAMA Cardiology
JANUARY 21, 2025
This cohort study investigates the association of supine hypertension with cardiovascular disease and mortality in middle-aged adults.
Open Heart
FEBRUARY 11, 2025
This study aimed to evaluate the risk factors associated with LV mass and subclinical coronary atherosclerosis, in an Asian population free of baseline cardiovascular disease. to 1.91), or hypertensive BP and high LVMI (RR 1.72, 95% CI 1.26
Frontiers in Cardiovascular Medicine
DECEMBER 20, 2023
Objectives To determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the IBERICAN cohort. This analysis shows the baseline clinical characteristics of patients with hypertension.
DAIC
MARCH 11, 2025
will establish the prevalence of endogenous hypercortisolism in patients with resistant hypertension. Resistant hypertension is defined by the American Heart Association as elevated blood pressure despite the use of three or more antihypertensive medications in different classes, including a diuretic.
Medical Xpress - Cardiology
FEBRUARY 23, 2024
Certain genes associated with hypertension affect blood pressure from early in life, and they increase the risk of cardiovascular disease as you get older. But you can do something about it.
Circulation
APRIL 10, 2025
Outcomes included adverse pregnancy outcomes associated with increased risk of cardiovascular disease and the American Heart Associations Lifes Essential 8 health factor components (blood pressure, lipids, glucose, and gestational weight gain).
DAIC
JUNE 20, 2024
milla1cf Thu, 06/20/2024 - 19:40 June 20, 2024 — A programing algorithm, being tested by HonorHealth Research Institute for those patients with new or recently installed pacemakers, is designed so the device not only provides a steady heartbeat, but also controls high blood pressure.
Frontiers in Cardiovascular Medicine
APRIL 4, 2024
Hypertension is a leading cause of morbidity and mortality worldwide and poses a major risk factor for cardiovascular diseases and chronic kidney disease.
Frontiers in Cardiovascular Medicine
MARCH 14, 2025
BackgroundCommunity-based models of care with the involvement of pharmacists and other nonphysician healthcare professionals can help improve blood pressure (BP) control. Pharmacist care is one key element of the solution to the global burden of hypertension and cardiovascular diseases.
Physiologically Speaking
OCTOBER 11, 2024
This was one of my main research interests in graduate school when I was involved in projects related to the effects of sleep deprivation on blood vessel function (endothelial function)—a major risk factor for developing cardiovascular disease. Does the same protective effect of exercise also extend blood pressure?
Hypertension Journal
APRIL 2, 2025
Hypertension, Ahead of Print. BACKGROUND:Hypertensive disorders of pregnancy (HDP) increase cardiovascular disease risk. Blood pressure (BP) trajectories 20 weeks gestation predict HDP outcomes. Adjusted hazard ratios were higher among preeclampsia and gestational hypertension groups than for no HDP.
Science Daily - Heart Disease
DECEMBER 4, 2023
Hispanic/Latina women with a history of hypertensive disorders of pregnancy (HDP) -- conditions marked by high blood pressure during pregnancy -- are more likely to have abnormalities in their heart structure and function decades later when compared with women without a history of HDP, according to a new study.
DAIC
MARCH 18, 2024
and the first on the West Coast to use a new device aimed at lowering blood pressure in patients with difficult-to-treat hypertension. Patients with treatment-resistant high blood pressure often take upward of four medications to manage their condition,” Rader said. The entire procedure takes about an hour.
Frontiers in Cardiovascular Medicine
FEBRUARY 20, 2024
Background Current clinical guidelines on cardiovascular disease (CVD) do not specifically address the female population. The aim of this consensus is to know the opinion of a group of experts on the management of CVD in women. The lack of consensus in this group was mainly among gynecologists and primary care physicians.
American College of Cardiology
NOVEMBER 16, 2024
The goal of the BPROAD trial was to determine the efficacy and safety of an intensive blood pressure (BP)-lowering strategy in patients with type 2 diabetes mellitus (T2DM) and hypertension with respect to future cardiovascular disease (CVD) events.
Medical Xpress - Cardiology
JULY 15, 2024
A comparison of two risk prediction tools used to calculate an individual's risk of developing cardiovascular disease (CVD) suggests that the long-term, 30-year risk should be considered in addition to the short-term, 10-year risk to help inform when to begin medication therapy for stage 1 hypertension, or high blood pressure, according to new research (..)
DAIC
JUNE 18, 2024
A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovascular disease within the next 30 years, according to two new science reports. and Susan F. population.
Open Heart
AUGUST 30, 2024
Background The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England. Results The percentage of patients aged ≥45 years who had blood pressure screening recorded in the preceding 5 years decreased from 90% (March 2019) to 85% (March 2023).
Open Heart
FEBRUARY 22, 2024
Background High blood pressure (BP) is a major risk factor for cardiovascular disease (CVD). This finding should help define further studies on factors affecting CVD and mortality in people treated for hypertension in the general population.
Heart BMJ
APRIL 25, 2024
Objective Observational studies show that hypertensive disorders of pregnancy (HDPs) are related to unfavourable maternal cardiovascular disease (CVD) risk profiles later in life. to 1.38) per unit increase in the log odds of genetic liability to pre-eclampsia/eclampsia and gestational hypertension, respectively.
Heart BMJ
OCTOBER 10, 2024
The frequent concurrence of elevated blood pressure (BP) and type 2 diabetes markedly elevates the risk of cardiovascular disease and mortality. Finally, we outline the role of lifestyle changes and other pharmacological options in attenuating cardiometabolic risks in patients with type 2 diabetes.
JAMA Cardiology
OCTOBER 22, 2024
Hypertension is the leading modifiable risk factor for cardiovascular disease (CVD) in the US, affects 122 million adults, and is projected to exceed 180 million adults by 2050.
Hypertension Journal
DECEMBER 4, 2023
Hypertension, Ahead of Print. 1.89) higher risk of abnormal LV geometry after adjusting for blood pressure and other confounders. The proportion of the association mediated by current hypertension between HDP and LV ejection fraction was 0.09 (95% CI, 0.03–0.45), years at time of echocardiogram. Conclusions.In
Hypertension Journal
SEPTEMBER 15, 2024
Hypertension, Ahead of Print. Blood pressure guidelines serve as a beacon of best practice for the diagnosis and management of hypertension. In 2018, the European Society of Cardiology (ESC) and European Society of Hypertension (ESH) released a joint guideline for the management of hypertension.1
JAMA Cardiology
FEBRUARY 11, 2025
This clinical trial included 22386 individuals aged 60 years and older with hypertension. It found that targeting blood pressure below 130/80 mm Hg could sustainably reduce cardiovascular disease incidence by 25% and total mortality by 10%. Notably, frailty was not considered in the studys safety assessment.
Physiologically Speaking
JANUARY 10, 2024
Circadian rhythms in blood pressure and heart rate, among other functions, are crucial for cardiovascular health and preventing cardiovascular disease. This has profound implications for cardiovascular health. In general, light exposure increases nighttime blood pressure and heart rate.
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Background The level at which cumulative blood pressure (BP) can increase the risk of ASCVD in different age groups remains unclear. 7.24) for the elevated BP, stage 1 hypertension, and stage 2 hypertension groups, respectively, when compared with the normal BP group. 6.80), 3.38 (1.54–7.43), 7.43), and 3.13 (1.36–7.24)
Hypertension Journal
JANUARY 31, 2025
Hypertension, Ahead of Print. BACKGROUND:Hypertension is a major cardiovascular risk factor, yet traditional care often results in suboptimal blood pressure (BP) control at the population level. We implemented a remote hypertension management program that monitored home BP and titrated medications per algorithm.
DAIC
AUGUST 14, 2024
15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of caffeine per day on most days of the week could increase the susceptibility of healthy individuals to cardiovascular disease. All participants had their blood pressure and pulse measured and underwent a three-minute step test.
Medical Xpress - Cardiology
NOVEMBER 1, 2024
During winter, cold indoor temperatures can increase blood pressure, leading to hypertension and an increased risk of cardiovascular diseases (CVDs). While insulation and heating can keep homes warm, they may be expensive to install and maintain.
Journal of Clinical Investigation - Cardiology
FEBRUARY 3, 2025
The precise mechanisms of blood pressure (BP) regulation are not fully elucidated, and understanding BP regulation is crucial for managing hypertension and improving outcomes for cardiovascular disease. In this issue of the JCI, Wang et al.
Hypertension Journal
DECEMBER 11, 2023
Hypertension, Ahead of Print. Background:Hypertensive disorders of pregnancy are associated with cardiovascular disease; however, patterns of blood pressure (BP) recovery are understudied. Pregnancy BPs were obtained during prenatal visits; postpartum BPs were prospectively obtained through home monitoring.
Science Daily - Stroke
JULY 13, 2023
Expanding home blood pressure monitoring among US adults with hypertension could substantially reduce the burden of cardiovascular disease and save healthcare costs in the long term, according to a new study.
Hypertension Journal
DECEMBER 11, 2023
Hypertension, Ahead of Print. BACKGROUND:The long-term benefit of achieving the Japanese Society of Hypertension home systolic blood pressure (SBP) target of <125 mm Hg has not been fully evaluated. 2.00] for overall cardiovascular disease and 2.68 [95% CI, 1.34–5.38]
Journal of Cardiovascular Pharmacology
FEBRUARY 3, 2025
Hypertension is a major risk factor for cardiovascular disease (CVD), and a major contributor to global morbidity and mortality. Given that these two receptors are critical players in vasotone regulation, antagonizing them, such as by aprocitentan, would be expected to significantly reduce blood pressure in patients with rHTN.
Hypertension Journal
JUNE 17, 2024
Hypertension, Ahead of Print. It is now apparent that immune mediators including complement, cytokines, and cells of the innate and adaptive immune system contribute not only to blood pressure elevation but also to the target organ damage that occurs in response to stimuli like high salt, aldosterone, angiotensin II, and sympathetic outflow.
Circulation
NOVEMBER 11, 2024
Background:Dietary magnesium (Mg+2) deficiency has been linked to hypertension, chronic kidney disease, and cardiovascular disease. High sodium intake and reduced dietary Mg+2consumption are associated with elevated blood pressure.
Open Heart
MARCH 23, 2023
Background Hypertension is a silent killer that causes serious health issues in all parts of the world. It is risk factor for cardiovascular disease, stroke and kidney disease. Self-monitoring practice has been identified as an important component of hypertension management. and then exported to SPSS V.25
Open Heart
MARCH 1, 2024
Introduction Hypertension is the leading modifiable risk factor for cardiovascular disease and is implicated in half of all strokes and myocardial infarctions. One-third of the adults in Scotland have hypertension yet only a quarter of them have their blood pressure (BP) controlled to target (<140/90 mm Hg).
Hypertension Journal
FEBRUARY 19, 2024
Hypertension, Ahead of Print. To celebrate 100 years of AHA-supported cardiovascular disease research, this review article highlights milestone papers that have significantly contributed to the current understanding of the signaling mechanisms driving hypertension and associated cardiovascular disorders.
Hypertension Journal
JANUARY 2, 2024
Hypertension, Ahead of Print. Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide.
The British Journal of Cardiology
JUNE 11, 2024
Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). Cardiovascular consultation had been requested for all of the patients based on their primary clinical examination, vital signs, and electrocardiogram (ECG).
Stroke Journal
DECEMBER 9, 2024
BACKGROUND:The focus for reducing hypertension-related cardiovascular disease is the management of blood pressure. Participants were stratified by duration of recognized hypertension: normotensive (0 years), 5 years, 6 to 20 years, or 21+ years. Stroke, Volume 56, Issue 1 , Page 105-112, January 1, 2025.
Circulation
NOVEMBER 11, 2024
Background:Hypertension (HTN) is a major risk factor for cardiovascular disease (CVD) and is the leading cause of morbidity and mortality globally, with a rise in prevalence in low and middle-income countries (LMIC). The proportion of people aware of their HTN diagnosis was 69%, but only 60% of them were on anti-hypertensives.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content